Navigation Links
Findings advance use of adult stem cells for replacement bone

little choice but to take a trial-and-error approach to designing a growth-factor regime."

In the study, Mikos's team hit upon the idea of having the stem cells create the proper growth medium themselves. The group, which included graduate student Quynh Pham and postdoctoral research associate Upma Sharma, accomplished this by seeding discs of titanium mesh with stem cells and encouraging them to form extracellular matrix, or ECM, the boney, calcified deposit that gives bone its structural strength.

A comparison was then run on these pre-generated ECM constructs and on non-treated titanium scaffolds. The pre-treated surfaces encouraged calcification at a much faster rate. The researchers also found up to 75 times more calcium in the bone created by tissues in the pre-treated cultures.

"To me, the most important element of the research is that it may one day contribute to new treatment options for patients," said Datta, who is planning to enter medical school in the fall. "One of the reasons I want to become a surgeon is so I can help bring cutting-edge work from the laboratory into clinical practice."

Datta said one of the main reasons she chose to attend Rice was because of the tremendous opportunities available through Rice's Century Scholars Program. The program included funding for tuition as well as a chance to begin research in Mikos's lab during her freshman year.

"My research experience at Rice has been life-changing in ways I could never have imagined four years ago," Datta said. "I never anticipated I would be traveling to international conferences, for example, but from the very beginning Dr. Mikos treated me as a valuable member of his research team. He provided encouragement. He let me follow my ideas. In short, he is the perfect mentor."


'"/>

Source:Rice University


Page: 1 2

Related biology news :

1. Findings have implications for tracking disease, drugs at the molecular level
2. Research advances quest for HIV-1 vaccine
3. Inexpensive, mass-produced genes core of synthetic biology advances at UH
4. Study of genomic DNA leads to new advances in cancer diagnostics
5. Molecular models advance the fight against malaria
6. Researchers test new therapy for advanced melanoma
7. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
8. Major advance made on DNA structure
9. Wild grasses and man-made wheats advance research capabilities
10. Gene therapy advance treats hemophilia in mouse models
11. Scientists create digital bacteria to forge advances in biomedical research

Post Your Comments:
(Date:11/23/2009)... Iowa - The only swine vaccine available for the H...infected with the virus. The vaccination marks the...diagnosed with the pandemic flu., Iowa State Uni..., developed the vaccine this summer and has been s...a, Kansas and Illinois for several weeks., The l...
(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...
(Date:11/23/2009)...ional Institute of General Medical Sciences (NIGMS..., is investing $42.3 million for grants in scienti...O)." NIH developed the GO grant program to stimula... provided by the American Recovery and Reinvestmen...ects that promise to have a significant impact on ...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Platelet Rich Plasma 3A Does It Work 3F 58657 1Platelet Rich Plasma 3A Does It Work 3F 58657 2Platelet Rich Plasma 3A Does It Work 3F 58657 3Platelet Rich Plasma 3A Does It Work 3F 58657 4DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 1DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 2Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 1Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 2
...urned on to target and destroy foreign infectious ...n, it is just as important to turn the immune syst.... The fruit fly Drosophila has served as a good mo..., pointing to conserved pathways and mechanisms. R...more subtly regulated and produces a wider range o...
...ld at the University of Edinburgh, 3-6 September 2... fingers, faeces and flies: food and waterborne pa...s. , Hepatitis E virus (HEV), which can be fatal,...veloping countries but scientists in the Netherlan...e contracting the virus from pork. It is one of fe...
...els in coastal waters interfere with fish reproduc...cientist from The University of Texas at Austin Ma...seasonal low levels of oxygen, known as hypoxia, h...ghout the world over the past few decades, largely...ultural and industrial activities. Hypoxias long-t...
Other Biology News:Society for General Microbiology 161st Meeting, University of Edinburgh 2Low oxygen in coastal waters impairs fish reproduction 2
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...Newswire-Asia/--ShanghaiBiolaxyannouncedthe,Chines...the,investigationalnewdrugapplication(IND)foritsor...lationtotreatdiabetes.ThisIND,approvalallowsBiolax...betesisadisordercharacteristicofhighbloodglucosean...sultinseveremicro-and,macro-vasculardiseases,losso...
(Date:11/24/2009)..., TORONTO,Nov.24/PRNewswire-FirstCall/-HamiltonT...eadingproviderofadvancedlasersystemsandinstruments...dayreportedoperationalandfinancialresultsforthethi...ts,-Revenuewas$1.46millioncomparedwith$1.43millio...with66.1percentinQ3,2008,-Netlossreducedto$148,000...
(Date:11/24/2009)...er24/PRNewswire/--HealthRoboticstodayannounced,tha...lected,investors.ThisrecentlyformedToronto-basedco...Inc.andwillmarket,install,andsupport,HealthRobotic...lutionaryproductofferingsi.v.STATION(TM),i.v.SOFT(...ovideassistanceonan"asneeded,basis"toitsstrategicp...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...AN DIEGO, Sept. 10 ADVENTRX Pharmaceuticals,Inc. ...elopment company,focused on commercializing propri...er and infectious diseases, announced today that i... Drug Administration (FDA) regarding its,proposed ...th for ANX-514,(docetaxel emulsion). The FDA has i...
...ompany to Hold a Conference Call Tomorrow (Tuesday...the Clinical Trial, Valley Cottage, NEW YORK, Sep...TLB ; LSE: XTL; TASE: XTL) today announced,the ini...e - a serotonin,and norepinephrine reuptake inhibi...thic pain. Bicifadine is being developed for the ...
...OUTH SAN FRANCISCO, Calif., Sept. 7 Monogram,Bios...t William D. Young, CEO,and Chairman, is scheduled...y Partners, G5: The Growth Conference on Monday, S...a.m. Pacific Time) at the St. Regis,Hotel in San F...oadcast or the subsequent archived,recording, log ...
Other Biology Technology:ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 2ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 3ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Mouse Anti-Human HVEM Cell Surface Staining Monoclonal Antibodies, Allophycocyanin Conjugated, 94801 from R&D Systems
... Osmometer for 10 L sample. Ideal for small volum...iatric, general adult, veterinary and experimental...selected values. Includes built-in printer, keypa...-keeping. Optional barcode scanner available. RS...
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: